Consultants Forum Advertise
Subscribe
Close

  • Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues

Subscribe Now
Renew

Area Development - Site Selection, Facility Planning and Workforce Development

Sema4 Relocates Laboratory to Stamford, Connecticut

04/05/2018
Sema4, a Mount Sinai venture providing advanced genomic testing, is planning grow its presence in Connecticut, relocating laboratory facilities from New York City to a yet-to-be-determined site in Stamford, Connecticut. The move will bring the company’s job presence in Connecticut to at least 553 employees.

The health information technology company is also moving forward with expansions at its two existing locations in the state, including its recently announced headquarters at 333 Ludlow Street in Stamford and its laboratory at 1 Commercial Street in Branford.

Sema4, a patient-centered predictive health company, is founded on the idea that more data, deeper analysis, and increased engagement with patients will improve the diagnosis, treatment, and prevention of disease. The company offers advanced genome-based diagnostics for reproductive health and oncology and is building predictive models of complex disease.

“Connecticut offers a very attractive environment for our company to grow along the talent-rich biotech corridor running from New York City to New Haven, with a stellar pool of qualified candidates, plus competitively-priced commercial real estate and the presence of leading universities and medical centers,” Eric Schadt, PhD, founder and CEO of Sema4, said. “We greatly appreciate the strong support from the State of Connecticut to foster our growth, which has facilitated the establishment of our corporate headquarters and accelerated the expansion of our laboratory operations here in Stamford.”

The Department of Economic and Community Development will provide a $6 million loan that will be utilized for the purchase of machinery and equipment, capital improvements, and the creation of 408 jobs in Connecticut. The company is eligible for partial loan forgiveness if certain milestones are met. In December 2015, DECD provided the company a $9.5 million loan to create 145 jobs in the state.

“Sema4’s decision to move its New York City lab operations to Connecticut is evidence that this is a great place to grow a business,” Department of Economic and Community Development Commissioner Catherine Smith said. “We are thrilled with Sema4’s decision to relocate its primary diagnostic testing laboratory from New York City and add to the community of bioscience firms in the state.”

“We are thrilled that Sema4 has chosen to significantly expand its operations in Connecticut, bringing their total workforce to over 550,” Governor Dannel P. Malloy said. “It’s no surprise that this cutting-edge, health information company has decided to grow here, thanks to our first-class talent pipeline and exceptional educational institutions. Today’s announcement isn’t just about economic development, it’s about a vision we began years ago to turn Connecticut into a hub for bioscience and tech growth. Thanks to our targeted investments, that vision is coming to life.”

Exclusive Research